Loyola otolaryngologist offers tips to identify, treat ear infection in children
Earaches in babies are not uncommon. But a baby's inability to communicate symptoms can leave most parents feeling helpless. According to the American Academy of Pediatrics, three-fourths of babies...
View ArticleVaccines - a needle-free future? An interview with Thomas Johnston and Dr....
Scientists recognize that 90% of pathogens actually enter the body through the mucosa and secondly, we have evolved a mucosal defense system that can be used to defend against disease...
View ArticleVaccine containing virus-like nanoparticles could be novel treatment option...
A vaccine containing virus-like nanoparticles, or microscopic, genetically engineered particles, is an effective treatment for respiratory syncytial virus (RSV), according to researchers at Georgia...
View ArticleChildren increase parents’ risk for viral infection
The BIG LoVE (Utah Better Identification of Germs-Longitudinal Viral Epidemiology) study, led by scientists at the University of Utah School of Medicine, finds that each bundle of joy puts the entire...
View ArticleEnvironmental and lifestyle factors contribute to development of celiac disease
Celiac disease incidence has increased among Swedish children between 2 to 15 years. The significant escalation in celiac disease can be associated with planned caesarean sections, urinary tract...
View ArticleNew vaccine candidate shows great promise at fighting respiratory syncytial...
Johns Hopkins Bloomberg School of Public Health researchers say a new candidate vaccine against respiratory syncytial virus (RSV) made with a weakened version of the virus shows great promise at...
View ArticleNew data shows ALS-008176 drug safe and effective against RSV infection
Alios BioPharma, Inc., part of the Janssen Pharmaceutical Companies announced that the New England Journal of Medicine will publish findings from a respiratory syncytial virus (RSV) challenge study for...
View ArticleLuminex's NxTAG Respiratory Pathogen Panel obtains FDA clearance
Luminex Corporation today announced that it has received FDA clearance for its NxTAG Respiratory Pathogen Panel that detects 20 clinically relevant viral and bacterial respiratory pathogens, including...
View ArticleDuke researchers closer to developing rapid blood test for bacterial and...
Researchers at Duke Health are fine-tuning a test that can determine whether a respiratory illness is caused by infection from a virus or bacteria so that antibiotics can be more precisely prescribed.
View ArticleBD launches new, wireless rapid diagnostic system for detection of flu, RSV...
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of its next generation wireless rapid diagnostic system for detection of influenza A and B,...
View ArticleNew research finds remarkable similarity between infant's nose and lung cells
Cells from an infant's nose are remarkably similar to those found in the lungs, a discovery that could lead to much more precise diagnosis of respiratory syncytial virus (RSV) and other infant lung...
View ArticleBabies in Canada's north face alarming rates of respiratory infection, study...
Infants in Canada's north are facing alarming rates of respiratory infection, but providing an antibody to all infants will prevent hundreds of hospitalizations of babies in the Arctic and save...
View ArticleCepheid introduces new Xpert Xpress Flu/RSV test that delivers results in 20...
With the flu season fast approaching, healthcare providers no longer need to choose between a fast test result or an accurate test result for patients suspected of influenza infection.
View ArticleCombatting Antibiotic Resistance, the role of POC Diagnostics
During the winter months, patients frequently present with respiratory symptoms like coughing, sneezing and fever that could be caused by one of several bacterial and viral infections including...
View ArticleTexas A&M professor shares tips to protect infants from RSV
Coughing, sneezing and a runny nose: You might think it is yet another cold, but if your baby is under 2 years old, it could very well be respiratory syncytial virus (RSV).
View ArticleCommon viruses pose serious challenges in long-term care facilities
A widespread outbreak of respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) at a long-term dementia care ward infected 73 percent of patients, demonstrating the serious challenges in...
View ArticleScientists discover critical role of biological molecule in protecting...
Scientists have discovered that a biological molecule important in cell growth (STAT3) is also critical in protecting us against infection - so much so that we would be unable to fight the common flu...
View ArticlePenn scientists find cytokine as key to fighting and treating viral infection...
Viral infections that occur in a patient's lungs are a significant cause of hospitalization and death among children and the elderly.
View ArticlePreterm babies given monoclonal antibody appear less likely to develop...
Preterm babies given the monoclonal antibody palivizumab to prevent respiratory syncytial virus (RSV) also appear less likely to develop recurrent wheeze, at least until the age of six, according to...
View ArticleResearchers develop new antiviral strategy to combat respiratory syncytial virus
Researchers from VIB, UGent, the Geisel School of Medicine at Dartmouth and several collaborators developed a new antiviral strategy to fight human respiratory syncytial virus (RSV), a leading cause of...
View Article